Asian Institute Of Nephrology And Urology (Siliguri) Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 19.78 Cr
as on 18-07-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 424.84%
(FY 2023)
- Profit 65.47%
(FY 2023)
- Ebitda 129.92%
(FY 2023)
- Net Worth -0.58%
(FY 2023)
- Total Assets -1.73%
(FY 2023)
About Asian Institute Of Nephrology And Urology (Siliguri)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 19.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Purna Kondakindi, Mallikarjuna Chiruvella, and Joydeep Ghose serve as directors at the Company.
- CIN/LLPIN
U85300TG2019PTC134128
- Company No.
134128
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Asian Institute Of Nephrology And Urology (Siliguri)?
Board Members(3)
Financial Performance and Corporate Structure Insights of Asian Institute Of Nephrology And Urology (Siliguri).
Asian Institute Of Nephrology And Urology (Siliguri) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 424.84% increase. The company also saw a substantial improvement in profitability, with a 65.47% increase in profit. The company's net worth dipped by a decrease of 0.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asian Institute Of Nephrology And Urology (Siliguri)?
In 2023, Asian Institute Of Nephrology And Urology (Siliguri) had a promoter holding of 91.07% and a public holding of 8.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asian Institute Of Nephrology And Urology (Chennai) Private Limited
Active
7 years 18 days Purna Kondakindi and Mallikarjuna Chiruvella are mutual person
Asian Institute Of Nephrology And Urology (Vizag) Private Limited
Active 6 years 7 months Purna Kondakindi and Mallikarjuna Chiruvella are mutual person
Asian Institute Of Nephrology And Urology Private Limited
Active 13 years 3 months Purna Kondakindi and Mallikarjuna Chiruvella are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asian Institute Of Nephrology And Urology (Siliguri)?
Asian Institute Of Nephrology And Urology (Siliguri) has a workforce of 120 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of May 31, 2022, Asian Institute Of Nephrology And Urology (Siliguri) has raised a total of ₹ 21.14 Cr, with the most recent deal valued at ₹ 3.5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
